NRG-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
US6890751B2 · kind B2 · utility
4Cited by
3References
15Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | May 23, 2001 |
| Grant date | May 10, 2005 |
| Priority date | — |
| Expiry date | Jun 19, 2022 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/52
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention features methods of treatment and diagnosis using NRG-2 polypeptides, nucleic acid molecules, and antibodies. The invention also provides novel NRG-2 polypeptides and nucleic acid molecules.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.